Medtronic Inc. received FDA clearance of the Reveal DX Insertable Cardiac Monitor (ICM) designed to help physicians identify the cause of unexplained fainting or abnormal heart rhythms, including ventricular tachyarrhythmias (VT), fast ventricular tachyarrhythmias (FVT), bradyarrhythmias and asystole.
February 5, 2008 - The Medical Imaging & Technology Alliance (MITA), a division of NEMA, said today that the budget ...
The Sentinel by Spacelabs reportedly integrates an entire range of noninvasive diagnostic cardiology solutions including ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
When cardiologists send their high-risk patients home, they may be protected with a host of tools, including implantable cardiac devices and pacemakers and strict regimens of medications. While the tools and regimens are powerful, cardiologists know that they are still limited when it comes to preventing adverse events. Without constant check-ups, serious coronary issues can occur.
A new 320-slice computed tomography (CT) system, the AquilionONE by Toshiba America Medical Systems, delivers dynamic ...
February 5, 2008 - The FAMILION test for Long QT Syndrome (LQTS) has met the Blue Cross and Blue Shield Association ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
The HeartStation ECG management system automates the processing and storage of electrocardiograms to reportedly improve ...
February 4, 2008 – Fluke Biomedical unveiled today new defibrillator and pacemaker analyzer technologies, the Impulse 6000D Defibrillator Analyzer and the Impulse 7000DP Defibrillator/Pacer Analyzer, which are designed to be rugged, portable test instrumentation for biomedical technical professionals to ensure proper operation and ultimate performance of critical life-support cardiac resuscitati
February 4, 2008 - The Centers for Medicare & Medicaid Services (CMS) announced that after completing a review of its 1986 national non-coverage policy for artificial hearts, its preliminary decision is to provide reimbursement for patients who receive the CardioWest temporary Total Artificial Heart (TAH-t) as part of FDA studies that meet CMS specifications.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Fluke Biomedical's product line of defibrillator and pacemaker analyzer technologies includes the Impulse 6000D ...
February 4, 2008 - InSite One Inc.
February 1, 2008 - Stentys' bifurcated stent was successfully implanted recently into a 49-year-old male patient at the ThoraxCenter, Erasmus Medical Center, Rotterdam, the Netherlands, marking the sixth successful implantation of the Stentys bifurcated stent platform.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
February 1, 2008 - Medtronic Inc. has received approval from the FDA for the Endeavor Zotarolimus-Eluting Coronary Stent ...
January 31, 2008 - Stentys' bifurcated stent was successfully implanted recently into a 49-year-old male patient at the ...
February 1, 2008 - Abbott has received reimbursement approval in France for its XIENCE V Everolimus Eluting Coronary ...
February 04, 2008
